Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

23 June 2020 : Laboratory Research  

A PD-L1 Aptamer Selected by Loss-Gain Cell-SELEX Conjugated with Paclitaxel for Treating Triple-Negative Breast Cancer

Xiaoqiu Wu123BEF, Fangfei Li123AG, Yongshu Li1BF, Yuanyuan Yu13DF, Chao Liang13C, Baoting Zhang4DE, Chuanzong Zhao56B, Aiping Lu12378AG, Ge Zhang123AG*

DOI: 10.12659/MSM.925583

Med Sci Monit 2020; 26:e925583

Table 2 IC50 value of RS, XQ-P3, RS-PTX and XQ-P3-PTX after 72 hours incubation with MDA-MB-231 PD-L1 OE cells, MDA-MB-231 PD-L1 KO cells and HCC1937 cells.

Cell linesIC50 (nM)
RSXQ-P3RS-PTXXQ-P3-PTX
MDA-MB-231 PD-L1 OEN/AN/A70.9222.07
MDA-MB-231 PD-L1 KON/AN/A93.0581.01
HCC-1937N/AN/A75.1734.19

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750